This preclinical-stage vaccine is a recombinant protein vaccine ... built upon a 30-year-long academic collaboration between a nanotechnology research team at Kyoto University and a cancer ...
Scientists from the world's leading universities have developed an all-in-one vaccine that they hope can protect humans against a broad range of coronaviruses, including ones that are yet to emerge.